Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Fakih

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
Expert Review of Anticancer Therapy|September 2, 2008
Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach?Marwan Fakih
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Biologic therapies in colorectal cancer: indications and contraindicationsMarwan Fakih
The Lancet. Oncology|May 1, 2007
Anti-EGFR monoclonal antibody-induced hypomagnesaemiaMarwan Fakih
Journal of Gastrointestinal Oncology|September 12, 2017
The International Duration Evaluation of Adjuvant Chemotherapy study: implications for clinical practiceMarwan Fakih
JAMA|March 16, 2026
ORCHESTRA Hits a Sour Note for Debulking in Metastatic Colorectal CancerMarwan Fakih
Current Treatment Options in Oncology|February 25, 2009
The role of targeted therapy in the treatment of advanced colorectal cancerMarwan Fakih
Future Oncology (London, England)|April 9, 2013
Targeting mechanisms of resistance to anti-EGF receptor therapy in KRAS wild-type colorectal cancer: the path to more personalized medicineMarwan Fakih
Journal of Gastrointestinal Oncology|September 3, 2013
Targeted therapies in colorectal cancer: the dos, don'ts, and future directionsMarwan Fakih
American Journal of Therapeutics|May 17, 2013
A case of fibrolamellar cancer with a palliative response and minor radiographic regression with erlotinib and bevacizumab combination therapyMarwan Fakih
Expert Review of Anticancer Therapy|February 26, 2013
The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancerMarwan Fakih
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
Expert Review of Anticancer Therapy|September 2, 2008
Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach?Marwan Fakih
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Biologic therapies in colorectal cancer: indications and contraindicationsMarwan Fakih
The Lancet. Oncology|May 1, 2007
Anti-EGFR monoclonal antibody-induced hypomagnesaemiaMarwan Fakih
Journal of Gastrointestinal Oncology|September 12, 2017
The International Duration Evaluation of Adjuvant Chemotherapy study: implications for clinical practiceMarwan Fakih
JAMA|March 16, 2026
ORCHESTRA Hits a Sour Note for Debulking in Metastatic Colorectal CancerMarwan Fakih
Current Treatment Options in Oncology|February 25, 2009
The role of targeted therapy in the treatment of advanced colorectal cancerMarwan Fakih
Future Oncology (London, England)|April 9, 2013
Targeting mechanisms of resistance to anti-EGF receptor therapy in KRAS wild-type colorectal cancer: the path to more personalized medicineMarwan Fakih
Journal of Gastrointestinal Oncology|September 3, 2013
Targeted therapies in colorectal cancer: the dos, don'ts, and future directionsMarwan Fakih
American Journal of Therapeutics|May 17, 2013
A case of fibrolamellar cancer with a palliative response and minor radiographic regression with erlotinib and bevacizumab combination therapyMarwan Fakih
Expert Review of Anticancer Therapy|February 26, 2013
The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancerMarwan Fakih
Pageof 20